The Team that Just Wouldn't Quit and a New Paradigm in Cancer Drug Discovery.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31519309.
- Also identified by DOI 10.1016/j.cell.2019.08.028.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Receiving the Lasker award for Clinical Medical Research is a staggering event. Perhaps equally staggering is the fact that as many as 2 million women worldwide have now been treated with Herceptin (trastuzumab), many of whom benefited from the treatment. This accomplishment is wonderfully rewarding for everyone who has been involved.